- Home
- EP vs PBYI Comparison
EP vs PBYI Comparison
Compare EP & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- PBYI
- Stock Information
- Founded
- EP 1983
- PBYI 2010
- Country
- EP United States
- PBYI United States
- Employees
- EP N/A
- PBYI N/A
- Industry
- EP Oil & Gas Production
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- EP Energy
- PBYI Health Care
- Exchange
- EP Nasdaq
- PBYI Nasdaq
- Market Cap
- EP 248.9M
- PBYI 153.2M
- IPO Year
- EP N/A
- PBYI N/A
- Fundamental
- Price
- EP $6.51
- PBYI $3.09
- Analyst Decision
- EP
- PBYI Strong Buy
- Analyst Count
- EP 0
- PBYI 1
- Target Price
- EP N/A
- PBYI $7.00
- AVG Volume (30 Days)
- EP 31.6K
- PBYI 754.5K
- Earning Date
- EP 11-14-2024
- PBYI 02-27-2025
- Dividend Yield
- EP N/A
- PBYI N/A
- EPS Growth
- EP N/A
- PBYI 492.79
- EPS
- EP N/A
- PBYI 0.47
- Revenue
- EP $43,254,386.00
- PBYI $243,569,000.00
- Revenue This Year
- EP N/A
- PBYI N/A
- Revenue Next Year
- EP N/A
- PBYI N/A
- P/E Ratio
- EP N/A
- PBYI $6.63
- Revenue Growth
- EP 10.97
- PBYI 6.30
- 52 Week Low
- EP $4.06
- PBYI $2.23
- 52 Week High
- EP $8.46
- PBYI $7.73
- Technical
- Relative Strength Index (RSI)
- EP 44.48
- PBYI 49.17
- Support Level
- EP $6.43
- PBYI $2.92
- Resistance Level
- EP $8.12
- PBYI $4.06
- Average True Range (ATR)
- EP 0.38
- PBYI 0.29
- MACD
- EP -0.13
- PBYI 0.01
- Stochastic Oscillator
- EP 4.73
- PBYI 27.07
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.